Dr. Joaquim Bellmunt

He combines being the Director of the Bellmunt Oncology Institute at the Hospital Universitari Dexeus · Grupo Quirónsalud with being the Director of the Bladder Cancer Clinic of the Dana Farber Cancer Institute of Harvard in Boston (USA).

He is an Associate Professor at Harvard. His areas of interest in research are Genito-Urinary clinical oncology, drugs focused on new therapeutic targets and early and transitional clinical research in the area of growth factor receptors and angiogenesis, among others, as the targets of cancer therapy. He is a member of the American Society for Cancer Research, of the American Clinical Oncology Association, of the European Medical Oncology Association and of the Spanish Medical Oncology Association.